
From Ancient Wisdom to AI: How Verve Therapeutics Rewrites the Future of Heart Health, One Gene at a Time
In a world grappling with inherited diseases, Verve Therapeutics is pioneering a new path. This Boston-based startup, backed by significant investment, is using AI and Crispr base editing to offer a one-time treatment for common heart conditions, promising a future where genetic predispositions no longer dictate destiny.

Xiomàra Hernándèz



















